Pure Global

Abbott clinical biochemically activated aspartate transaminase assay set - Taiwan Registration 1d08001a3e73e62c8174ee5798bd0ea6

Access comprehensive regulatory information for Abbott clinical biochemically activated aspartate transaminase assay set in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 1d08001a3e73e62c8174ee5798bd0ea6 and manufactured by ABBOTT IRELAND DIAGNOSTICS DIVISION. The authorized representative in Taiwan is ABBOTT LABORATORIES SERVICES LLC TAIWAN BRANCH (U.S.A.).

This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
89,000+ Devices
1d08001a3e73e62c8174ee5798bd0ea6
Registration Details
Taiwan FDA Registration: 1d08001a3e73e62c8174ee5798bd0ea6
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing

Device Details

Abbott clinical biochemically activated aspartate transaminase assay set
TW: ไบžๅŸน่‡จๅบŠ็”ŸๅŒ–ๆดปๅŒ–ๅž‹ๅคฉ้–€ๅ†ฌๆฐจ้…ธ่ฝ‰่ƒบ้…ถๆชข้ฉ—่ฉฆๅŠ‘็ต„
Risk Class 2

Registration Details

1d08001a3e73e62c8174ee5798bd0ea6

DHA05603520402

Company Information

Product Details

This product is used to quantify aspartate aminotransferase in human serum or plasma on the ARCHITECT c system.

A Clinical chemistry and clinical toxicology

A.1100 ๅคฉ้–€ๅ†ฌ่ƒบ้…ธ่ฝ‰่ƒบ้…ถ่ฉฆ้ฉ—็ณป็ตฑ

QMS/QSD;; ่ผธๅ…ฅ

Dates and Status

Jan 12, 2022

Jan 12, 2027